Evidence map›Paper›PMID 41133265›Full record

ArticleBMJ neurology open2025

Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Anna Walz, Daria Tkachenko, Martin W Hümmert, Patrick Schindler, Judith Bellmann-Strobl, Friedemann Paul, Orhan Aktas, Marius Ringelstein, Katrin Giglhuber, Clarissa Zappe and 19 more

Abstract read
In one paragraph

Article in BMJ neurology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Anna Walz *Department of Neurology, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0009-0001-0005-6800
Daria Tkachenko *Department of Neurology, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0009-0003-5647-8038
Martin W HümmertDepartment of Neurology, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0002-5928-2343
Patrick SchindlerNeuroscience Clinical Research Centre (NCRC), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Judith Bellmann-StroblNeuroscience Clinical Research Centre (NCRC), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-2615-1643
Friedemann PaulNeuroscience Clinical Research Centre (NCRC), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Orhan AktasDepartment of Neurology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Marius RingelsteinDepartment of Neurology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID https://orcid.org/0000-0003-3618-8407
Katrin GiglhuberDepartment of Neurology, School of Medicine, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.
Clarissa ZappeDepartment of Neurology, School of Medicine, Technical University Munich, Klinikum Rechts der Isar, Munich, Germany.
Frank LeypoldtDepartment of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany.
Felix LüssiDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Ilya AyzenbergDepartment of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Carolin SchwakeDepartment of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.ORCID https://orcid.org/0000-0003-3669-7244
Ulrike WallwitzDepartment of Neurology, Martha-Maria Hospital Halle-Doelau, Halle (Saale), Germany.
Julian Reza KretschmerDepartment of Neurology, Hannover Medical School, Hannover, Germany.
Franziska BütowDepartment of Neurology, Hannover Medical School, Hannover, Germany.
Klemens AngstwurmDepartment of Neurology, University of Regensburg, Regensburg, Germany.ORCID https://orcid.org/0000-0003-3220-8829
Leila HusseiniDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.ORCID https://orcid.org/0009-0005-9243-9735
Vivien HäußlerDepartment of Neurology and Institute of Neuroimmunology and MS (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID https://orcid.org/0000-0002-7787-7391
Florian Then BerghDepartment of Neurology, University of Leipzig, Leipzig, Germany.
Axel HaarmannDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Dominik LehriederDepartment of Neurology, University of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0002-2339-8598
Clemens WarnkeDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-3510-9255
Tania KümpfelInstitute of Clinical Neuroimmunology, LMU University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-7509-5268
Daniel EngelsInstitute of Clinical Neuroimmunology, LMU University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-9877-6987
Tanja Zimmermann *Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0002-5069-7278
Corinna Trebst *Department of Neurology, Hannover Medical School, Hannover, Germany.
Neuromyelitis Optica Study Group (NEMOS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated diseases (MOGAD) impose psychological burdens on patients. Chronic illnesses create challenges for both patients and their partners, who also play a crucial role in managing disease-related stress. Despite its relevance, little is known about the role of dyadic coping (DC) in these conditions. This study investigates DC in NMOSD and MOGAD, aiming to provide clinical recommendations. Methods: The CoMMOnsense-Study is a cross-sectional, prospective study of 59 NMOSD and 50 MOGAD patients and their respective partners, recruited from 15 centres of the German Neuromyelitis Optica Study Group registry. Participants completed self-report questionnaires on DC, depression, anxiety and quality of relationship. Correlation analyses were performed to compare findings based on antibody status. Subsequently, multivariate regression analyses were conducted to identify relevant predictors of DC. Results: Patients with NMOSD and MOGAD demonstrated higher levels of depressive symptoms (NMOSD: p=0.007; MOGAD: p=0.023) and stress communication scores (NMOSD: p=0.022; MOGAD: p=0.013) than their partners. Negative coping was low across all subgroups (Stanine 1). Despite high DC and relationship quality, discrepancies were observed in the coping perceptions between partners. Conclusions: Coping is highly shared within partnerships affected by NMOSD and MOGAD, while discrepancies in coping perceptions and protective buffering suggest the presence of unfavourable coping mechanisms. Reducing protective buffering and illness-related distortions shows potential areas for enhancing DC.

Indexed as

DEPRESSIONNEUROIMMUNOLOGY

Identifiers

PMID41133265
PMCPMC12542533

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.